Appellate court rejects appeal of patent for common ED drug found to be overbroad
The Federal Court of Appeal has dismissed an appeal concerning a patent for a common erectile dysfunction (ED) drug that the Federal Court had found was invalid....To view the full article, register now.
Already a subscriber? Click here to view full article